Literature DB >> 9483534

Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens.

X Y Lu1, M B Ghasemzadeh, P W Kalivas.   

Abstract

In situ hybridization was combined with FluoroGold retrograde labelling to determine the distribution of messenger RNAs for the D1 dopamine receptor, D2 dopamine receptor, beta-preprotachykinin or preproenkephalin in the neurons projecting from the nucleus accumbens to the ventral pallidum and the ventral tegmental area. Neurons were quantified in both the core and the shell of the nucleus accumbens to estimate the proportion of neurons projecting to the ventral pallidum or ventral tegmental area that contain transcripts for D1 receptors, D2 receptors, beta-preprotachykinin or preproenkephalin. Following the deposition of FluoroGold into the central ventral pallidum, both the core and the shell of the nucleus accumbens were retrogradely labelled, while deposits into the ventral tegmental area selectively labelled cells in the shell. A high percentage of nucleus accumbens neurons innervating the ventral tegmental area expressed messenger RNAs for D1 receptors (72%) and beta-preprotachykinin (62%), while less than 3% of the neurons contained messenger RNAs for preproenkephalin or D2 receptors. The neurons projecting to the ventral pallidum did not show the discrete distribution of transcripts as was observed in the accumbens-ventral tegmental area projection. Preproenkephalin messenger RNA was identified in 46% of the neurons innervating the ventral pallidum, and D2 receptor messenger RNA was found in approximately 40% of the cells. A large minority of neurons projecting from the nucleus accumbens to the ventral pallidum also expressed messenger RNAs for D1 receptors (37%) and beta-preprotachykinin (35%). While a higher percentage of D1 receptor, and beta-preprotachykinin messenger RNA expressing cells were located in the shell than in the core of the nucleus accumbens, the percentage tended to be higher in the core for cells expressing D2 receptors or preproenkephalin messenger RNA. These data indicate that messenger RNAs for D2 receptors and enkephalin are selectively expressed in the accumbens-pallidal projection while transcripts encoding D1 receptors and substance P are contained in the efferent projections to both the ventral pallidum and ventral tegmental area. The presence of D1 receptor and beta-preprotachykinin messenger RNAs in both mesencephalic and pallidal projections contrasts output from the striatum where the expression of D1 receptor and beta-preprotachykinin messenger RNAs is primarily restricted to the mesencephalic projection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9483534     DOI: 10.1016/s0306-4522(97)00327-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  107 in total

1.  Adenosine A2A receptors in the nucleus accumbens bi-directionally alter cocaine seeking in rats.

Authors:  Casey E O'Neill; McKenzie L LeTendre; Ryan K Bachtell
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

Review 2.  New medications for drug addiction hiding in glutamatergic neuroplasticity.

Authors:  P W Kalivas; N D Volkow
Journal:  Mol Psychiatry       Date:  2011-04-26       Impact factor: 15.992

3.  Striatal cell type-specific overexpression of DeltaFosB enhances incentive for cocaine.

Authors:  Christina R Colby; Kim Whisler; Cathy Steffen; Eric J Nestler; David W Self
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

4.  Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal.

Authors:  Anna K Radke; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

Review 5.  Striatal mechanisms underlying movement, reinforcement, and punishment.

Authors:  Alexxai V Kravitz; Anatol C Kreitzer
Journal:  Physiology (Bethesda)       Date:  2012-06

6.  Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system.

Authors:  Jun Wang; Sebastien Carnicella; Somayeh Ahmadiantehrani; Dao-Yao He; Segev Barak; Viktor Kharazia; Sami Ben Hamida; Agustin Zapata; Toni S Shippenberg; Dorit Ron
Journal:  J Neurosci       Date:  2010-10-27       Impact factor: 6.167

7.  Nucleus Accumbens AMPA Receptor Trafficking Upregulated by Food Restriction: An Unintended Target for Drugs of Abuse and Forbidden Foods.

Authors:  Kenneth D Carr
Journal:  Curr Opin Behav Sci       Date:  2016-06

Review 8.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

9.  Cell-Type-Specific Regulation of Nucleus Accumbens Synaptic Plasticity and Cocaine Reward Sensitivity by the Circadian Protein, NPAS2.

Authors:  Puja K Parekh; Ryan W Logan; Kyle D Ketchesin; Darius Becker-Krail; Micah A Shelton; Mariah A Hildebrand; Kelly Barko; Yanhua H Huang; Colleen A McClung
Journal:  J Neurosci       Date:  2019-04-08       Impact factor: 6.167

10.  Nucleus accumbens dopamine mediates amphetamine-induced impairment of social bonding in a monogamous rodent species.

Authors:  Yan Liu; Brandon J Aragona; Kimberly A Young; David M Dietz; Mohamed Kabbaj; Michelle Mazei-Robison; Eric J Nestler; Zuoxin Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.